49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details


臨床試験数 : 993 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-121864
01/6/2012A Phase I study of rontalizumabA Phase I study of rontalizumab Systemic lupus erythematosus (SLE)Intervention name : Rontalizumab
Dosage And administration of the intervention : Single and multiple subcutaneous administration of 3 different doses of rontalizumab
Control intervention name : null
Chugai Pharmaceutical Co., Ltd.NULL2064BOTH21Phase 1NULL
2NCT00962832
(ClinicalTrials.gov)
September 200919/8/2009A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus ErythematosusA Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) in Patients With Moderately to Severely Active Systemic Lupus ErythematosusSystemic Lupus ErythematosusDrug: Placebo;Drug: RontalizumabGenentech, Inc.NULLCompleted18 Years65 YearsBoth238Phase 2United States;Argentina;Colombia;Mexico;Poland;Russian Federation;United Kingdom